Kidney Cancer section

Kidney Cancer News & Features

Nivolumab plus ipilimumab improve survival in advanced renal cell carcinoma

1. Amongst patients with advanced renal-cell carcinoma and an intermediate or poor prognosis, nivolumab plus ipilimumab was superior to sunitinib alone in improving overall survival. 2. Though not statistically compared, there was a lower incidence of grade three or four adverse events with nivolumab plus ipilimumab, although more patients in the combination therapy arm stopped []

Relative Visceral Fat Area an Indicator of Mortality Risk for Women With RCC

Relative Visceral Fat Area an Indicator of Mortality Risk for Women With RCC

An evaluation of patients with clear cell renal cell carcinoma revealed greater risk of death for female patients with high relative visceral fat area (rVFA), highlighting the significance of metabolic differences between men and women.

Nephrectomy Outcomes Better With Partial Procedure vs Radical Procedure

Nephrectomy Outcomes Better With Partial Procedure vs Radical Procedure

The employment of radical nephrectomy, vs partial nephrectomy, was found to cause a 2-fold greater decline in eGFR decline and greatly increased mortality.

Radical Cystectomy Outcomes Worsen With Higher Stage Chronic Kidney Disease

Radical Cystectomy Outcomes Worsen With Higher Stage Chronic Kidney Disease 

The presence of CKD may increase chances for poor outcomes following radical cystectomy for urothelial carcinoma of the bladder.

Axitinib Plus Pembrolizumab Shows Promise in Treatment-Naïve Advanced RCC

Axitinib Plus Pembrolizumab Shows Promise in Treatment-Naïve Advanced RCC

Nonrandomized trial demonstrates tolerability and antitumor activity of a PD-1 checkpoint inhibitor plus a VEGF-TKI in patients with treatment-naïve advanced RCC.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs